Filed: June 04, 2021 00:00
Coverage
-
November 02, 2022
The Patent Trial and Appeal Board dealt LabCorp a blow by rejecting its arguments that 37 claims in a Ravgen Inc. prenatal genetic testing patent — including the claim at the heart of a $272 million Texas jury verdict — are invalid.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Search PTAB cases and full-text documents.
- Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
- Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!
TRY LAW360 FREE FOR SEVEN DAYS